Get started
BIONANO GENOMICS INC USD0.0001 (POST REVERSE SPLIT)BIONANO GENOMICS INC USD0.0001 (POST REVERSE SPLIT)BIONANO GENOMICS INC USD0.0001 (POST REVERSE SPLIT)

BIONANO GENOMICS INC USD0.0001 (POST REVERSE SPLIT)

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

0A4K trade ideas

Need to check if today's candle closes with a hammer candleHello traders! If you "Follow" us, you can always get new information quickly. Please also click “Boost”. Have a good day. ------------------------------------- (BNGO 1M chart) It is renewing its low point by falling below the HA-Low indicator point of 6.49. Touching the HA-Low indicator point means that there is a high possibility of forming a low point. A decline from the HA-Low indicator point is likely to lead to a renewed low, but also a move to form a bottom. The 1M chart should be interpreted from a long-term perspective, so it is expected to show movement to form a bottom for a long period of time. (1W chart) The HA-Low indicator is falling, showing a stepwise decline. Accordingly, it is time to buy when it rises above 1.37 and shows support. (1D chart) When you see the 1M, 1W chart, you can see that it is absolutely not the time to start trading. Additionally, the 1D chart also shows that this is not the time to start trading. However, looking at the current candlestick, there is a possibility that the trend will change. Accordingly, you need to check whether it shows an up and down movement or sideways movement at the current price range. If it is supported and rises from the HA-Low indicator, it is likely to rise near the HA-High indicator. Therefore, if there is a swing up or down from the current price position, the HA-Low indicator will be created, and if it is supported by the created HA-Low indicator and rises above 1.08, there is a possibility of a short-term uptrend. In order to continue the upward trend, it is highly likely that the HA-High indicator and MS-Signal indicator must rise above. Therefore, the key is whether it can rise above the current HA-High indicator point of 1.75. However, since the psychological volume profile section is formed around 1.25, we must first check whether it is possible to break above this section. Have a good time. thank you -------------------------------------------------- - The big picture The full-fledged upward trend is expected to begin when the price rises above 29K. This is the section expected to be touched in the next bull market, 81K-95K. #BTCUSD 12M 1st: 44234.54 2nd: 61383.23 3rd: 89126.41 101875.70-106275.10 (when overshooting) 4th: 13401.28 151166.97-157451.83 (when overshooting) 5th: 178910.15 These are points that are likely to encounter resistance in the future. We need to see if we can break through these points upward. Since it is thought that a new trend can be created in the overshooting zone, you should check the movement when this zone is touched. #BTCUSD 1M If the general upward trend continues until 2025, it is expected to rise to around 57014.33 and then create a pull back pattern. 1st: 43833.05 2nd: 32992.55 -----------------
NASDAQ:BNGO
by readCrypto
BNGO Pharma Huge FailBNGO has shown very negative performance, as this chart will demonstrate. Using the Cloud Trend Pattern Method has not yet shown an entry position, however this could soon revert. Keeping this one on my watch list for a possible +300% Upside, but as all Pharma will need a Catalyst. As always please get a few expert's advice before making any Trade or Investment choices. Whilst this Ticker can offer a great upside potential, it's only advised you test a small <1% position should you be interested. And, Smash that Rocket Boost button to show your appreciation for my Chart Study.
NASDAQ:BNGO
by hitchcoxg
9
BNGO Trading Strategy: Market Analysis and Profit TargetsStrong Support: BNGO presents a buying opportunity. Market Structure: The weekly chart shows the completion of impulse waves 1, 2, 3, 4, and 5, and now we are entering correction waves ABCD. Stop Loss: Set at the Fibonacci extension of 127.2 (equivalent to $1.10). Profit Targets: Fibonacci Retracement between 0.5 ($10.7) and 0.618 ($13). First Target: $10. Here, I suggest taking 20% of the profits. Second Target: $12. At this level, taking another 20% of the profits is recommended. Final Target: $24. This is the point where I recommend taking the largest portion of the profits, which is the remaining 100% of the position. PS: From my perspective, I plan to keep 20% of my position until it reaches $40. Risk Management: My strategy involves a clear plan for taking profits at various levels, aiding in risk management, and securing gains. Personal Opinion: This reflects my opinion, and I encourage others to consider taking profits in a staggered manner, as per my suggested levels. It's essential to understand that this is a personal viewpoint and strategy. Market conditions can shift unpredictably. Traders should do their own research and assess their risk tolerance before adopting any trading strategy. Please be aware that this analysis represents my perspective and is not professional financial advice. I am not a financial advisor. Each individual should research thoroughly and consider all risks before making investment decisions. Markets are inherently unpredictable, so informed and cautious trading is always advisable.
NASDAQ:BNGOLong
by MarketPax
9
BNGO Trading Strategy: Market Analysis and Profit Targets PART 2BNGO offers a strong buying opportunity with an anticipated price surge. Market Structure: The 2W chart reveals a completed bullish butterfly pattern XABCD. The yellow circle highlights the three instances of price explosions. Fibonacci Retracements: * X to A at 0.786 for point B * A to B ranging between 0.382 and 0.886 for point C * X to A at 1.272 for point D, serving as the Stop Loss * Stop Loss Range: between 1.272 and 1.41. Profit Targets: * 1TP (First Target Price): $14.46 * 2TP (Second Target Price): $20.35 * 3TP (Third Target Price): $27.16 * Final Target: $40 I've included an image of the monthly chart where the RSI (Relative Strength Index) and MACD (Moving Average Convergence Divergence) indicators are bullish. Notably, there have been three instances of bullish divergence coinciding with significant price increases. Currently, there's a bullish signal with the RedK EVERX crossing below -70 for the first time. On the 2W chart, the RSI is showing a bullish crossover, and the MACD has already crossed, further supported by the RedK EVERX crossing below -70. Risk Management: My strategy includes a structured plan for realizing profits at predetermined levels, which aids in managing risks and ensuring gains. Personal Opinion: This is my viewpoint. I recommend others to consider taking profits in a staggered manner, according to the levels I have outlined. Please note that this is a subjective analysis. Market conditions are prone to change unpredictably. Traders should conduct their research and evaluate their risk tolerance before implementing any trading strategy. Part 1: Please be aware that this analysis represents my perspective and is not professional financial advice. I am not a financial advisor. Each individual should research thoroughly and consider all risks before making investment decisions. Markets are inherently unpredictable, so informed and cautious trading is always advisable.
NASDAQ:BNGOLong
by MarketPax
BNGO 15min BNGO 15min trendline, breakout bearish pennant w/measured move $0.5954. $2.31 is next resistance and target price before continuation of correction. Correction to $0.47-$0.55. Retracement back to $2.31. Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.
NASDAQ:BNGOLong
by TheCryptoChartWhisperer
1
BNGO Down 90% in 1 YearBionaro Stock is down +-90% in 1 Year. Clearly a mismanaged Company from the market sentiment valuation. Can they give the market a surprise similar to other MEDICAL type Genome Stocks? To date there has been little information released on any marketing or social media, so we will have to wait for now. However - should they release positive information, this stock has the potential to perform a few x as seen of late with other similar tickers. A great example of why one needs to get out early or minimise RISK to less than 1% of your Capital. To Date there are NO signals on my 1 Year study to show any potential upside. Should you like my STUDY ANALYSIS - Please smash the Rocket Button. Regards Graham.
NASDAQ:BNGOShort
by hitchcoxg
8
BNGO 1W Bangertest Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. The firm engages in the development and marketing of Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.
NASDAQ:BNGOLong
by TheCryptoChartWhisperer
5
$BNGO - Supply & DemandTrying to keep this as imple as possible and adding perspective. Bullish: - Scarce or none bearish presence from the 0.5-1 level - Gargantouan rally springing from that level with convergent volume Bearish: - The depth of the downtrends denotes that although the bears are shy but strong when stepping in from the 9-11$ price range. Any prominet set up here? Textbook supply & demand set up. 1. Bulky rally with high momentum candles erupting from 0.5-1$ level, validated by volume. 2.Shy but steady retacement to the same level. 3. Whoever bought and cause that rally back in 2020 is buying again and giving us a buy trigger. We have a logical place where to set a stop loss. 2 profit targets ... woudl just be extra due dilligent with the risk managemet here. Perhaps doubling the emphazis on the position size snce this market seems to be so prone to violent moves. Rememnber: 1. current candle, which for now is giving us a trigger, is not yet closed (20 left). Be patient. 2. There are no certainties in trading. The price might as well fall and close below support which would give us a sell signal. The name of the game is not predicting, but instead reacting well, managing risk, find good r/r setups, stay a alive, repeat a zillion times in order to allow the odds to help you out and manage all the emotions that will be begging you to deviate from your plan.
NASDAQ:BNGOLong
by ruben_rodrigues
5
Bionano in trouble? Bionano Short Term - We look to Sell at 1.78 (stop at 2.04) Preferred trade is to sell into rallies. The trend of lower highs is located at 1.85. Our outlook is bearish. We have a 38.2% Fibonacci pullback level of 1.80 from 2.84 to 1.18. Bespoke resistance is located at 1.85. Our profit targets will be 1.18 and 1.01 Resistance: 1.85 / 2.50 / 3.00 Support: 1.50 / 1.00 / 0.50 Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features. Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
NASDAQ:BNGOShort
by Saxo
BNGO Ready to Break? Bionano Genomics - Short Term - We look to Buy a break of 2.52 (stop at 2.25) A break of yesterdays high would confirm bullish momentum. Posted a Double Bottom formation. The measured move target is 3.36. We look for gains to be extended today. Our profit targets will be 3.13 and 3.30 Resistance: 2.50 / 3.00 / 4.00 Support: 2.00 / 1.70 / 1.50 Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features. Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
NASDAQ:BNGOLong
by Saxo